Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment

DATROWAY receives US priority review for first-line metastatic triple negative breast cancer

Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil

Lupin launches Dasatinib tablets in US market

WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals

Natera submits Signatera CDx PMA to FDA for bladder cancer use

Pharming receives FDA complete response letter for paediatric Joenja application

Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer

I Peace generates human iPS cells from NKT cells and offers them for research use

Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA

Frontage expands early phase clinical research capabilities across US and China

AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC

Ascletis Pharma Inc reports topline results from Phase III open-label study of denifanstat

Innovative Molecules GmbH completes Phase 1 clinical development programme for adibelivir

MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA